Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Dec. 12, 2018. Victor Roberts.

Executive Summary

In the second part of Medtech Insight's two-part series on the blood glucose monitoring devices market, Victor Roberts, an endocrinologist at the University of Central Florida in Orlando, said that some diabetes apps can be a useful tool for managing diabetes, but patients and doctors should be careful not to overrely on them.

"There has to be a sense by the physician that the use of diabetes technology is not the destination – not to be enamored with the high-tech toys that we now have at our disposal … It's a GPS to get us to our destination. " - Victor Roberts, endocrinologist, University of Central Florida

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT124367

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel